Consolidated net sales for the second quarter of the fiscal year ending March 2027 were 210,870 million yen (YoY +13.0%), operating income was 13,112 million yen (YoY +68.4%), and interim net income attributable to owners of parent was 11,682 million yen (YoY +105.1%), marking significant increases. A revision to the full-year forecast was announced. By segment, Takara Shuzo Group, Takara Shuzo International Group, and Takara Bio Group are expected to be the primary drivers of overall growth.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"2531","jir_company_name":"Takara Holdings Inc.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-11-10","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/11\/2531-20261110-01.pdf","jir_short_summary":"Consolidated net sales for the second quarter of the fiscal year ending March 2027 were 210,870 million yen (YoY +13.0%), operating income was 13,112 million yen (YoY +68.4%), and interim net income attributable to owners of parent was 11,682 million yen (YoY +105.1%), marking significant increases. A revision to the full-year forecast was announced. By segment, Takara Shuzo Group, Takara Shuzo International Group, and Takara Bio Group are expected to be the primary drivers of overall growth.","jir_summary":"### Overview of Results\nFor the interim period of this fiscal year, consolidated net sales increased significantly to 210,870 million yen compared with the same period last year. By segment, strong performance from the Takara Shuzo Group, Takara Shuzo International Group, and Takara Bio Group lifted overall results, with operating income of 13,112 million yen and interim net income attributable to owners of parent of 11,682 million yen, representing substantial profit growth. Supplementary explanatory materials for the financial results have been published, and revisions to future performance forecasts are included.\n\n### Outlook and Capital Allocation\nA revision to the full-year outlook has been announced, expecting revenue and profit growth led by the Takara Shuzo International Group and Takara Bio Group, while overall financial condition remains sound. Details on investment plans and capital policy should be referenced in separate documents; the supplementary materials outline progress on the Long-Term Plan 2030 and a policy emphasizing ROIC.","jir_financial_highlights":"Net Sales: 210,870 (YoY seven-digit range, +13.0%)\nOperating Income: 13,112 (YoY +68.4%)\nInterim Net Income Attributable to Owners of Parent: 11,682 (YoY +105.1%)\nRevision to Full-Year Forecast: Refer to the announced \"Notice Regarding Revision of Consolidated Earnings Forecasts for the Fiscal Year Ending March 2027\" (Unknown)","jir_category":"","jir_hashtags":"#TakaraHoldings, #Earnings, #Interim, #MidTermPlan2030","jir_key_figures":"Net Sales: 210,870 million yen\nOperating Income: 13,112 million yen\nInterim Net Income: 11,682 million yen","jir_meta_title":"Takara Holdings Inc. FY2027 Q2 Results | Net Sales +13%, Profit Expansion","jir_meta_description":"Summary of Takara Holdings Inc.'s FY2027 Q2 results: net sales 210,870 million yen, operating income 13,112 million yen, interim net income attributable to owners of parent 11,682 million yen. Includes notice of revision to full-year forecast.","jir_og_title":"Takara Holdings Inc. \u2014 Key Points of Q2 Results","jir_og_description":"Takara Holdings Inc.'s Q2 results show net sales up 13% YoY and substantial profit growth. Revision to full-year forecast announced.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":8130,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-147113","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n